Education - Cancer companies usually accompany data readouts, conference posters or presentations with various types of graphs and plots to represent the outcomes. This note will go … Continue Reading
Read NowEducation - In the last Biotech Basics notes, we covered how to interpret data readouts, and what determines a successful study (details here). Due to the importance … Continue Reading
Read NowEducation - In the last Biotech Basics notes, we covered how to spot incoming financings (read here) and how dilutive instruments can manipulate valuations (read here). This … Continue Reading
Read NowEducation - Biotechnology companies often need to raise capital to fund research and development of their pipeline. In a prior note (read here), we outlined what metrics … Continue Reading
Read NowEducation - Bio investing is driven by near-term catalysts, rather than a buy & hold strategy. There is a 7.9% likelihood of FDA approval from Phase 1, … Continue Reading
Read NowEducation - New investors often confused medical device 510k clearance with FDA approval. The hurdles are quite different. Here's what you need to know.
Read NowEducation - Generic pharmaceuticals are drug products designed to be functionally identical (bioequivalent) to brand name drugs in terms of the active ingredient, dosage strengths, forms, indications, … Continue Reading
Read Now
